MX2010012836A - Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos. - Google Patents
Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos.Info
- Publication number
- MX2010012836A MX2010012836A MX2010012836A MX2010012836A MX2010012836A MX 2010012836 A MX2010012836 A MX 2010012836A MX 2010012836 A MX2010012836 A MX 2010012836A MX 2010012836 A MX2010012836 A MX 2010012836A MX 2010012836 A MX2010012836 A MX 2010012836A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- inflammatory
- methods
- pharmaceutical formulations
- steroidal anti
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Una forma de dosificación oral de un fármaco antiinflamatorio no esteroideo (AINE) se hace más segura para uso prolongado o crónico para terapia antiinflamatoria, analgésica o antipirética mediante la combinación con un fármaco antihipertensivo. El fármaco antihipertensivo actúa profilácticamente para inhibir o reducir la hipertensión inducida por AINE y al hacerlo los efectos secundarios cardiovasculares adversos de los AINEs, tales como presión arterial alta, ataques al corazón, ataque de apoplejía, complicaciones oftalmológicas, y muerte, cuando los AINEs se usan repetidamente en un periodo prolongado de tiempo para reducir inflamación o en manejo del dolor.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5678908P | 2008-05-28 | 2008-05-28 | |
US9797208P | 2008-09-18 | 2008-09-18 | |
PCT/US2009/044966 WO2009154944A2 (en) | 2008-05-28 | 2009-05-22 | Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010012836A true MX2010012836A (es) | 2011-09-27 |
Family
ID=41434626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010012836A MX2010012836A (es) | 2008-05-28 | 2009-05-22 | Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos. |
Country Status (7)
Country | Link |
---|---|
US (2) | US20110207724A1 (es) |
EP (1) | EP2285371A4 (es) |
JP (1) | JP2011525479A (es) |
AU (1) | AU2009260632A1 (es) |
CA (1) | CA2726337A1 (es) |
MX (1) | MX2010012836A (es) |
WO (1) | WO2009154944A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3151822A4 (en) * | 2014-06-08 | 2017-11-22 | Autotelic LLC | Fixed dose combination for pain relief without edema |
WO2019067768A2 (en) * | 2017-09-28 | 2019-04-04 | Nevakar, Inc. | FIXED DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN |
US20210393553A1 (en) * | 2018-11-01 | 2021-12-23 | Imuneks Farma Ilac Sanayi Ve Ticaret A.S. | Pharmaceutical combinations for the treatment of pain |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5155120A (en) * | 1991-01-14 | 1992-10-13 | Pfizer Inc | Method for treating congestive heart failure |
US20040186155A1 (en) * | 2003-01-30 | 2004-09-23 | Dayno Jeffrey Marc | Combination therapy for the treatment or prevention of migraine |
WO2006102476A2 (en) * | 2005-03-21 | 2006-09-28 | Vicus Therapeutics Spe 1, Llc | Compositions and methods for ameliorating cachexia |
US20070037797A1 (en) * | 2005-08-15 | 2007-02-15 | Hellstrom Harold R | Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events |
-
2009
- 2009-05-22 US US12/990,724 patent/US20110207724A1/en not_active Abandoned
- 2009-05-22 EP EP09767256A patent/EP2285371A4/en not_active Ceased
- 2009-05-22 MX MX2010012836A patent/MX2010012836A/es unknown
- 2009-05-22 WO PCT/US2009/044966 patent/WO2009154944A2/en active Application Filing
- 2009-05-22 AU AU2009260632A patent/AU2009260632A1/en not_active Abandoned
- 2009-05-22 CA CA2726337A patent/CA2726337A1/en not_active Abandoned
- 2009-05-22 JP JP2011511735A patent/JP2011525479A/ja active Pending
-
2016
- 2016-05-02 US US15/144,188 patent/US20160243134A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20160243134A1 (en) | 2016-08-25 |
US20110207724A1 (en) | 2011-08-25 |
WO2009154944A3 (en) | 2010-04-01 |
EP2285371A4 (en) | 2012-01-25 |
WO2009154944A2 (en) | 2009-12-23 |
AU2009260632A1 (en) | 2009-12-23 |
EP2285371A2 (en) | 2011-02-23 |
CA2726337A1 (en) | 2009-12-23 |
JP2011525479A (ja) | 2011-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200810125B (en) | Pharmaceutical combination comprising 3- (3-dimethy-lamin0-1-ethyl-2-methyl-pr0pyl)-phenol and an NSAID | |
WO2007012022A3 (en) | Unit dose form with ibuprofen-famotidine admixture | |
DK2043637T3 (da) | Fremgangsmåder og medikamenter til administrering af ibuprofen | |
MX358636B (es) | Formulaciones farmacéuticas de naproxeno para la encapsulación en gel blando y combinaciones de las mismas. | |
MX2012005689A (es) | Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos. | |
NZ602029A (en) | Use of meloxicam for the long-term treatment of kidney disorders in cats | |
WO2009004995A1 (ja) | 生理活性物質を定着および発現させる方法 | |
EA200901237A1 (ru) | Применение димирацетама при лечении хронической боли | |
MX2010012836A (es) | Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos. | |
NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
HN2011000661A (es) | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual | |
WO2019067768A4 (en) | Fixed dose combination formulations for treating pain | |
JP2011525479A5 (es) | ||
RU2015112586A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
AR055807A1 (es) | Composicion farmaceutica sinergistica de diclofenaco y clonixinato de lisina | |
AR081007A1 (es) | Combinacion farmaceutica caracterizada porque comprende ibuprofeno y l-arginina | |
AR059081A1 (es) | Composicion farmaceutica estable de carisoprodol y meloxicam | |
WO2013100881A3 (en) | Combined pharmaceutical formulation containing diacerein | |
EA201000810A1 (ru) | Фармацевтическая композиция | |
MX2017015630A (es) | Efecto analgesico local de la combinacion del acido docosahexaenoico dha y naproxeno. | |
WO2006081088A3 (en) | Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid | |
AR060205A1 (es) | Composicion farmaceutica sinergistica de carisoprodol y clonixinato de lisina | |
AR075414A1 (es) | Composiciones y metodos para terapia extendida con aminopiridinas | |
EA201200238A1 (ru) | Комбинированная противотуберкулезная композиция | |
PE20160038A1 (es) | Composicion farmaceutica sinergistica de dos analgesicos con distinto perfil farmacocinetico |